It was previously reported that among subjects with a COPD exacerbation, those in whom NIV was unsuccessful presented a higher level of serum inflammatory markers (PCT and CRP) compared to subjects in whom NIV was applied successfully [11]. The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.